These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 10136547)

  • 21. Multi-purpose evaluation of H2-antagonist usage.
    Gianarkis D
    Hosp Formul; 1992 May; 27(5):527-30, 532. PubMed ID: 10117769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Financial impact of formulary revision of second-generation cephalosporins.
    Andrews JD; Hafting S
    Can J Hosp Pharm; 1988 Jun; 41(3):125-7. PubMed ID: 10288499
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing physician prescribing habits through a cost-effective first generation cephalosporin formulary.
    Cramer R; Wright C
    Hosp Pharm; 1989 Jan; 24(1):33-8. PubMed ID: 10312858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Key inventory to formulary to cut drug costs.
    Schmieding JL; Sita MJ
    Hospitals; 1980 Sep; 54(17):78-81. PubMed ID: 7399457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness of an enteral products formulary.
    Durfee DD; Skinner-Domet VM
    Am J Hosp Pharm; 1984 Nov; 41(11):2352-4. PubMed ID: 6439034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Savings achieved through cephalosporin surveillance.
    Katz E; Schlamowitz S
    Am J Hosp Pharm; 1978 Dec; 35(12):1521-3. PubMed ID: 717407
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost savings through formulary implementation and group purchasing in four therapeutic categories.
    Sylvester KL; Wudds TW
    Hosp Formul; 1986 Mar; 21(3):357-60, 369-70. PubMed ID: 10275579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of formulary development in a small hospital.
    Holt RT; Larson DS; Scheil ES
    Hosp Pharm; 1988 Jul; 23(7):649-52, 656, 666. PubMed ID: 10288268
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacoeconomics and the formulary decision-making process.
    Bakst A
    Hosp Formul; 1995 Jan; 30(1):42-50. PubMed ID: 10172201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a pharmacy-based cost-containment program on cimetidine costs and use.
    Kong KM; Johnson WF; Anderson PO; Sato LA; Simonian RI
    Am J Hosp Pharm; 1987 Sep; 44(9):2068-73. PubMed ID: 3674045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formulary conversion from glipizide to glyburide: a cost-minimization analysis.
    Nadel HL
    Hosp Pharm; 1995 Jun; 30(6):467-9, 472-4. PubMed ID: 10142848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost savings achieved through cephalosporin use review and restriction.
    Dzierba SH; Reilly RT; Caselnova DA
    Am J Hosp Pharm; 1986 Sep; 43(9):2194-7. PubMed ID: 3766571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cimetidine and the cost of peptic ulcer in the Netherlands.
    Bulthuis R
    Eff Health Care; 1984 Apr; 1(6):297-311. PubMed ID: 10310799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ASHP technical assistance bulletin on assessing cost-containment strategies for pharmacies in organized health-care settings.
    Am J Hosp Pharm; 1992 Jan; 49(1):155-60. PubMed ID: 1570860
    [No Abstract]   [Full Text] [Related]  

  • 35. Prospective-pricing strategies for hospital and departmental effectiveness: the pharmacist's response.
    Gouveia WA
    Am J Hosp Pharm; 1985 Oct; 42(10):2164-8. PubMed ID: 3933335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of the British Columbia reference drug program on hospital formularies: a survey of hospital pharmacy managers.
    Gill NJ; Frighetto L; Marra C; Jewesson P
    Can J Clin Pharmacol; 2000; 7(2):109-14. PubMed ID: 10958707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibiotic therapy intervention at a community hospital. Opportunities for cost and quality improvements.
    Thrasher CM; Stefl ME; Dorner FH
    Hosp Top; 1995; 73(2):12-5. PubMed ID: 10144621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hospital drug therapy cost containment through a preferred medicines list and drug utilisation review system.
    Pearce MJ; Begg EJ
    N Z Med J; 1994 Mar; 107(974):101-4. PubMed ID: 8127505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Initiation of a clinical pharmacology consult service as a formulary management tool.
    Albertson T; Musallam N; Tharratt S; Romac D; Foulke G; Mowers R; Panecek E
    Hosp Formul; 1993 Aug; 28(8):699-702, 707. PubMed ID: 10127748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Achieving parenteral nutrition cost savings through prescribing guidelines and formulary restrictions.
    Maswoswe JJ; Newcomer DR; Quandt CM
    Am J Hosp Pharm; 1987 Jun; 44(6):1376-81. PubMed ID: 3113237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.